Breastcancer-genetics
21 – 30 of 2292
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
- Contribution to journal › Article
-
Mark
Preoperative prediction of nodal status using clinical data and artificial intelligence derived mammogram features enabling abstention of sentinel lymph node biopsy in breast cancer
- Contribution to journal › Article
-
Mark
A registry-based study on universal screening for defective mismatch repair in colorectal cancer in Denmark highlights disparities in screening uptake and counselling referrals
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
- Contribution to journal › Article
- 2023
-
Mark
Altered prerequisites : A cross-sectional survey regarding cancer care in Sweden during COVID-19 from the viewpoint of contact nurses in cancer care
- Contribution to journal › Article
-
Mark
Striving to excel–effects from vacation periods on cancer incidence and outcome
- Contribution to journal › Debate/Note/Editorial
-
Mark
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
- Contribution to journal › Article
-
Mark
Deciphering the normal-like molecular subtype of breast cancer
(2023) AACR Special Conference in Cancer Research: Advances in Breast Cancer Research
- Contribution to conference › Poster
-
Mark
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
(2023) AACR Special Conference in Cancer Research: Advances in Breast Cancer Research
- Contribution to conference › Poster
-
Mark
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer : data from the randomized SBII:2 trial
- Contribution to journal › Article
